Topas Therapeutics
Transforming the field of immune tolerance
- Website
- topas-therapeutics.com
- Total Funding
- $110.8M
- Last Round
- $48.0M Extension RoundJul 2021
- Rounds
- 4
About
Auto-Immunity
Summary
Topas Therapeutics is a Biotech company. It has raised $110.8M in total across 4 rounds, most recently a $48.0M Extension Round in Jul 2021. Investors include Epidarex Capital, Boehringer Ingelheim Venture Fund and BioMedPartners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2021
Sign up to see all 4 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...

Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/topas-therapeutics"><img src="https://indexed.vc/api/badge/company/topas-therapeutics" alt="Topas Therapeutics on Indexed.vc" width="260" height="76" /></a>

